SLC6A3 and ovarian carcinoma: A high expression of DAT/SLC6A3 mRNA was found in renal cell carcinoma, lung adenocarcinoma, prostate cancer, lung SCC, pancreatic cancer, ovarian cancer, stomach cancer, esophagus cancer, sarcoma, and head and neck cancer (Figure S8).